The introduction of a simple pre-fractionation step enabled the simultaneous proteomic comparison of the reduction in the dystrophin-glycoprotein complex and secondary changes in the mdx-4cv mouse model of dystrophinopathy in a single analytical run. Here, DMD is linked to neuromuscular disease caused by qualitative or quantitative defects of dystrophin.